<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Aptevo Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Aptevo Therapeutics Inc.

    Aptevo Therapeutics Inc. is a clinical-stage biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Aptevo has a commercial product, IXINITY® coagulation factor IX (recombinant), approved and marketed in the United States for the treatment of Hemophilia B, and a versatile core technology – the ADAPTIR™ modular protein technology platform capable of generating highly-differentiated bispecific antibodies with unique mechanisms of action to treat cancer and autoimmune diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Marvin L. White
    • FOUNDED
      2016
    • EMPLOYEES
      101-250
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Mighty Well, Inc.

    Mighty Well, Inc.

    The mission of Mighty Well is to help patients and their caregivers turn sickness ...

    The mission of Mighty Well is to help patients ...

    Amount Raised:    $99,995.00
    Fundraising Status:    EC
    Filing Type:    CF
    CAVU Biotherapies, Inc.

    CAVU Biotherapies, Inc.

    CAVU Biotherapies offers a comprehensive solution to prepare for, monitor, and tre...

    CAVU Biotherapies offers a comprehensive soluti...

    Filing Type:    CF
    Affimed Therapeutics

    Affimed Therapeutics

    At Affimed, we are committed to improving outcomes for patients with cancer. Our s...

    At Affimed, we are committed to improving outco...

    Filing Type:    PU
    Akibah Health Corporation

    Akibah Health Corporation

    GluCase is an all-in-one diabetes management system that seamlessly integrates a g...

    GluCase is an all-in-one diabetes management sy...

    Amount Raised:    $38,481.00
    Fundraising Status:    EC
    Filing Type:    CF
    Alterola Biotech, Inc.

    Alterola Biotech, Inc.

    Alterola Biotech Inc. provides medicinal delivery systems, offering nutraceutrical...

    Alterola Biotech Inc. provides medicinal delive...

    LIFE RECOVERY SYSTEMS HD LLC

    LIFE RECOVERY SYSTEMS HD LLC

    Cool your patients to a target temperature of 33ÂşC in about 30 minutes with Life ...

    Cool your patients to a target temperature of 3...

    Amount Raised:    $726,600.00
    Fundraising Status:    EC
    Filing Type:    CF
    Avalon GloboCare Corp.

    Avalon GloboCare Corp.

    Avalon GloboCare Corp. (NASDAQ: AVCO) is a global intelligent biotech developer an...

    Avalon GloboCare Corp. (NASDAQ: AVCO) is a glob...

    Filing Type:    PU
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    Surface Oncology, Inc.

    Surface Oncology, Inc.

    Surface Oncology is an immuno-oncology company on a mission to break through and d...

    Surface Oncology is an immuno-oncology company ...

    Filing Type:    PU
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    Constellation Pharmaceuticals, Inc.

    Constellation Pharmaceuticals, Inc.

    Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using ...

    Constellation Pharmaceuticals is a clinical-sta...

    Filing Type:    PU
    Heron Therapeutics, Inc.

    Heron Therapeutics, Inc.

    Our mission is to improve the lives of patients by developing novel, best-in-class...

    Our mission is to improve the lives of patients...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.